Deep01 is an AI-based software company, and currently focusing on Head CT images. Deep01 have been developed the world-leading AI-powered clinical decision support system, DeepCT, which can detect and quantify abnormalities on Head CT images. DeepCT helps emergency physicians to triage patients, neurosurgeon to assess treatments, and radiology to generate reports faster and more accurately. DeepCT, as a deep-learning software, obtains - 1st US FDA clearance in Asia-Pacific in 2019 - 1st Taiwan FDA clearance in the world in 2020 - 1st Japan FDA clearance in Taiwan in 2021 and ISO13485 / CE / Thailand FDA / Hong Kong FDA / Malaysia FDA clearances In 2022, a large-scale clinical trial was accepted and published by Journal of Medical System. This clinical trial collected almost 3000 patient data and demonstrated that using DeepCT can averagely save 3 hours and 40 minutes for patients with brain bleeds in the emergency room (LOS). This publication can be found https://link.springer.com/article/10.1007/s10916-022-01833-z Investor: Asus, ITRI(工研院), BE Capital, US Plug and Play